Application of the 2017 KDIGO Guideline for the Evaluation and Care of Living Kidney Donors to Clinical Practice.
Consensus
Data Analysis
Demography
Donor nephrectomy
Guideline
Kidney Diseases
Living Donors
Living donation
Patient-centered care
Renal Insufficiency
Risk Assessment
Risks
kidney
kidney transplantation
risk factors
Journal
Clinical journal of the American Society of Nephrology : CJASN
ISSN: 1555-905X
Titre abrégé: Clin J Am Soc Nephrol
Pays: United States
ID NLM: 101271570
Informations de publication
Date de publication:
08 06 2020
08 06 2020
Historique:
pubmed:
12
4
2020
medline:
21
10
2021
entrez:
12
4
2020
Statut:
ppublish
Résumé
The Kidney Disease: Improving Global Outcomes (KDIGO) 2017 "Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors" was developed to assist medical professionals who evaluate living kidney donor candidates and provide care before, during, and after donation. This guideline Work Group concluded that a comprehensive approach to donor candidate risk assessment should replace eligibility decisions on the basis of assessments of single risk factors in isolation. To address all issues important to living donors in a pragmatic and comprehensive guideline, many of the guideline recommendations were on the basis of expert consensus opinion even when no direct evidence was available. To advance available evidence, original data analyses were also undertaken to produce a "proof-of-concept" risk projection model for kidney failure. This was done to illustrate how the community can advance a new quantitative framework of risk that considers each candidate's profile of demographic and health characteristics. A public review by stakeholders and subject matter experts as well as industry and professional organizations informed the final formulation of the guideline. This review highlights the guideline framework, key concepts, and recommendations, and uses five patient scenarios and 12 guideline statements to illustrate how the guideline can be applied to support living donor evaluation and care in clinical practice.
Identifiants
pubmed: 32276946
pii: 01277230-202006000-00025
doi: 10.2215/CJN.12141019
pmc: PMC7274294
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
896-905Subventions
Organisme : NIDDK NIH HHS
ID : R01 DK120551
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK116042
Pays : United States
Organisme : CIHR
Pays : Canada
Informations de copyright
Copyright © 2020 by the American Society of Nephrology.
Références
Liyanage T, Ninomiya T, Jha V, Neal B, Patrice HM, Okpechi I, Zhao MH, Lv J, Garg AX, Knight J, Rodgers A, Gallagher M, Kotwal S, Cass A, Perkovic V: Worldwide access to treatment for end-stage kidney disease: A systematic review. Lancet 385: 1975–1982, 2015 25777665
Tonelli M, Wiebe N, Knoll G, Bello A, Browne S, Jadhav D, Klarenbach S, Gill J: Systematic review: Kidney transplantation compared with dialysis in clinically relevant outcomes. Am J Transplant 11: 2093–2109, 2011 21883901
Axelrod DA, Schnitzler MA, Xiao H, Irish W, Tuttle-Newhall E, Chang SH, Kasiske BL, Alhamad T, Lentine KL: An economic assessment of contemporary kidney transplant practice. Am J Transplant 18: 1168–1176, 2018 29451350
Klarenbach S, Barnieh L, Gill J: Is living kidney donation the answer to the economic problem of end-stage renal disease? Semin Nephrol 29: 533–538, 2009 19751899
Mahillo B, Carmona M, Álvarez M, White S, Noel L, Matesanz R: 2009 Global data in organ donation and transplantation: Activities, laws, and organization. Transplantation 92: 1069–1074, 2011 22005777
Horvat LD, Shariff SZ, Garg AX; Donor Nephrectomy Outcomes Research (DONOR) Network: Global trends in the rates of living kidney donation. Kidney Int 75: 1088–1098, 2009 19225540
Tong A, Chapman JR, Wong G, de Bruijn J, Craig JC: Screening and follow-up of living kidney donors: A systematic review of clinical practice guidelines. Transplantation 92: 962–972, 2011 21959214
Lentine KL, Kasiske BL, Levey AS, Adams PL, Alberú J, Bakr MA, Gallon L, Garvey CA, Guleria S, Li PK, Segev DL, Taler SJ, Tanabe K, Wright L, Zeier MG, Cheung M, Garg AX: KDIGO clinical practice guideline on the evaluation and care of living kidney donors. Transplantation 101[Suppl 1]: S1–S109, 2017 28742762
Lentine KL, Segev DL: Understanding and communicating medical risks for living kidney donors: A matter of perspective. J Am Soc Nephrol 28: 12–24, 2017 27591246
Lentine KL, Lam NN, Segev DL: Risks of living kidney donation: Current state of knowledge on outcomes important to donors. Clin J Am Soc Nephrol 14: 597–608, 2019 30858158
Massie AB, Muzaale AD, Luo X, Chow EKH, Locke JE, Nguyen AQ, Henderson ML, Snyder JJ, Segev DL: Quantifying postdonation risk of ESRD in living kidney donors. J Am Soc Nephrol 28: 2749–2755, 2017 28450534
Ibrahim HN, Foley RN, Reule SA, Spong R, Kukla A, Issa N, Berglund DM, Sieger GK, Matas AJ: Renal function profile in white kidney donors: The first 4 decades. J Am Soc Nephrol 27: 2885–2893, 2016 26888476
Freedman BI, Moxey-Mims M, Alexander A, Astor BC, Birdwell KC, Bowden DW, Bowen G, Bromberg J, Craven TE, Darshana DM, Divers J, Doshi MD, Eidbo E, Fornoni A, Gautreaux MD, Gbadegesin RA, Gee PO, Guerra G, Hsu CY, Iltis AS, Jefferson N, Julian BA, Klassen DK, Koty PP, Langefeld CD, Lentine KL, Ma L, Mannon RB, Menon MC, Mohan S, Moore JB, Murphy B, Newell KA, Odim J, Ortigosa-Goggins M, Palmer ND, Park M, Parsa A, Pastan SO, Poggio ED, Rajapakse N, Reeves-Daniel AM, Rosas SE, Russell LP, Sawinski D, Smith SC, Spainhour M, Stratta RJ, Weir MR, Reboussin DM, Kimmel PL, Brennan DC: APOL1 long-term kidney transplantation outcomes network (APOLLO): Design and rationale. Kidney Int Rep 5: 278–288, 2020
Chapman AB, Devuyst O, Eckardt KU, Gansevoort RT, Harris T, Horie S, Kasiske BL, Odland D, Pei Y, Perrone RD, Pirson Y, Schrier RW, Torra R, Torres VE, Watnick T, Wheeler DC; Conference Participants: Autosomal-dominant polycystic kidney disease (ADPKD): Executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int 88: 17–27, 2015 25786098
Pei Y, Hwang YH, Conklin J, Sundsbak JL, Heyer CM, Chan W, Wang K, He N, Rattansingh A, Atri M, Harris PC, Haider MA: Imaging-based diagnosis of autosomal dominant polycystic kidney disease. J Am Soc Nephrol 26: 746–753, 2015 25074509
Simms RJ, Travis DL, Durkie M, Wilson G, Dalton A, Ong AC: Genetic testing in the assessment of living related kidney donors at risk of autosomal dominant polycystic kidney disease. Transplantation 99: 1023–1029, 2015 25340609
Audrézet MP, Cornec-Le Gall E, Chen JM, Redon S, Quéré I, Creff J, Bénech C, Maestri S, Le Meur Y, Férec C: Autosomal dominant polycystic kidney disease: Comprehensive mutation analysis of PKD1 and PKD2 in 700 unrelated patients. Hum Mutat 33: 1239–1250, 2012 22508176
Rossetti S, Consugar MB, Chapman AB, Torres VE, Guay-Woodford LM, Grantham JJ, Bennett WM, Meyers CM, Walker DL, Bae K, Zhang QJ, Thompson PA, Miller JP, Harris PC; CRISP Consortium: Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 18: 2143–2160, 2007 17582161
Savige J, Rana K, Tonna S, Buzza M, Dagher H, Wang YY: Thin basement membrane nephropathy. Kidney Int 64: 1169–1178, 2003 12969134
Koushik R, Garvey C, Manivel JC, Matas AJ, Kasiske BL: Persistent, asymptomatic, microscopic hematuria in prospective kidney donors. Transplantation 80: 1425–1429, 2005 16340786
Choi SR, Sun IO, Hong YA, Kim HG, Park HS, Chung BH, Choi BS, Park CW, Kim YS, Yang CW: The role of kidney biopsy to determine donation from prospective kidney donors with asymptomatic urinary abnormalities. Transplant Proc 44: 11–13, 2012 22310565
Delmonico FL, Martin D, Domínguez-Gil B, Muller E, Jha V, Levin A, Danovitch GM, Capron AM: Living and deceased organ donation should be financially neutral acts. Am J Transplant 15: 1187–1191, 2015 25833381
Sickand M, Cuerden MS, Klarenbach SW, Ojo AO, Parikh CR, Boudville N, Garg AX; Donor Nephrectomy Outcomes Research Network: Reimbursing live organ donors for incurred non-medical expenses: A global perspective on policies and programs. Am J Transplant 9: 2825–2836, 2009 19788503
Garg AX, Nevis IF, McArthur E, Sontrop JM, Koval JJ, Lam NN, Hildebrand AM, Reese PP, Storsley L, Gill JS, Segev DL, Habbous S, Bugeja A, Knoll GA, Dipchand C, Monroy-Cuadros M, Lentine KL; DONOR Network: Gestational hypertension and preeclampsia in living kidney donors. N Engl J Med 372: 124–133, 2015 25397608
US Department of Health and Human Services: Advancing American kidney health: Available at: https://aspe.hhs.gov/system/files/pdf/262046/AdvancingAmericanKidneyHealth.pdf . Accessed November March 1, 2020
Ibrahim HN, Akkina SK, Leister E, Gillingham K, Cordner G, Guo H, Bailey R, Rogers T, Matas AJ: Pregnancy outcomes after kidney donation. Am J Transplant 9: 825–834, 2009 19353771
Lentine KL, Mandelbrot D: Moving from intuition to data: Building the evidence to support and increase living donor kidney transplantation. Clin J Am Soc Nephrol 12: 1383–1385, 2017 28818848
Garg AX: Helping more patients receive a living donor kidney transplant. Clin J Am Soc Nephrol 13: 1918–1923, 2018 30082336
O’Keeffe LM, Ramond A, Oliver-Williams C, Willeit P, Paige E, Trotter P, Evans J, Wadström J, Nicholson M, Collett D, Di Angelantonio E: Mid- and long-term health risks in living kidney donors: A systematic review and meta-analysis. Ann Intern Med 168: 276–284, 2018 29379948
Levey AS, Inker LA: GFR evaluation in living kidney donor candidates. J Am Soc Nephrol 28: 1062–1071, 2017 28298325
Lentine KL, Kasiske BL, Levey AS, Adams PL, Alberú J, Bakr MA, Gallon L, Garvey CA, Guleria S, Li PK, Segev DL, Taler SJ, Tanabe K, Wright L, Zeier MG, Cheung M, Garg AX: Summary of kidney disease: Improving global outcomes (KDIGO) clinical practice guideline on the evaluation and care of living kidney donors. Transplantation 101: 1783–1792, 2017 28737659
Inker LA, Koraishy FM, Goyal N, Lentine KL: Assessment of glomerular filtration rate and end-stage kidney disease risk in living kidney donor candidates: A paradigm for evaluation, selection, and counseling. Adv Chronic Kidney Dis 25: 21–30, 2018 29499883
Fagerlin A, Zikmund-Fisher BJ, Ubel PA: Helping patients decide: Ten steps to better risk communication. J Natl Cancer Inst 103: 1436–1443, 2011 21931068
Grams ME, Sang Y, Levey AS, Matsushita K, Ballew S, Chang AR, Chow EK, Kasiske BL, Kovesdy CP, Nadkarni GN, Shalev V, Segev DL, Coresh J, Lentine KL, Garg AX; Chronic Kidney Disease Prognosis Consortium: Kidney-failure risk projection for the living kidney-donor candidate. N Engl J Med 374: 411–421, 2016 26544982